We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Discover reasons your trial spending might exceed its budget and how to navigate the financial consequences of shifting study needs. A special bonus in the end - a checklist of 15 hidden costs you should be aware of before rolling out your study.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
